TIMOTHY MARTIN: Open Payments
NPI 1386716686 · ABILENE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,660 in 89 payments from 17 companies in 2025. Trend: 2023 $1,939 · 2024 $2,071 · 2025 $1,660
Food & beverage: $1,660
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $337 |
| AstraZeneca Pharmaceuticals LP | 16 | $287 |
| Vanda Pharmaceuticals Inc. | 7 | $229 |
| Axsome Therapeutics, Inc. | 10 | $175 |
| Novo Nordisk Inc | 9 | $159 |
| Otsuka America Pharmaceutical, Inc. | 6 | $117 |
| Lundbeck LLC | 4 | $104 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $49 |
| Dexcom, Inc. | 2 | $48 |
| GlaxoSmithKline, LLC. | 2 | $36 |
Products named: FANAPT, REXULTI, VRAYLAR, Ozempic, Auvelity, AIRSUPRA, BREZTRI, QULIPTA.
Industry payments across TX — which companies pay providers there.
